EGFR and hepatocellular carcinoma: Tumor area accumulation of the scAb-EGFR-targeted nanomedicines simultaneously labeled with MRI T2 contrast agent SPION and near-infrared fluorescence (NIRF) agent Alexa Fluor 750 in liver orthotropic HCC mice models was monitored by MRI and NIRF bimodal imaging.